Anika Therapeutics reported $173.47M in Current Assets for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acceleron Pharma XLRN:US $ 737.61M 155.66M
Acorda Therapeutics ACOR:US $ 189.72M 31.62M
Adamas Pharmaceuticals ADMS:US 158.1M 46.37M
Agenus AGEN:US $ 135.66M 21.88M
Agios Pharmaceuticals AGIO:US $ 2355.11M 1718.44M
Anika Therapeutics ANIK:US $ 173.47M 3.91M
Arrowhead Research ARWR:US $ 586.76M 263.04M
Clovis Oncology CLVS:US $ 252.51M 58.32M
Dicerna Pharmaceuticals DRNA:US $ 594.5M 24.2M
Enanta Pharmaceuticals ENTA:US $ 428.22M 17.72M
Flexion Therapeutics FLXN:US $ 204.62M 21.19M
Halozyme Therapeutics HALO:US $ 941.72M 386.96M
Heron Therapeutics HRTX:US $ 272.29M 41.91M
Immunogen IMGN:US $ 319.57M 4.68M
Insmed INSM:US $ 501M 121.89M
Integra Lifesciences IART:US $ 1.04B 198.13M
Intrexon XON:US $ 144.12M 4.83M
Karyopharm Therapeutics KPTI:US $ 255.51M 21.02M
Ligand Pharmaceuticals LGND:US $ 437.43M 63.13M
Macrogenics MGNX:US $ 374.72M 62.12M
Merit Medical Systems MMSI:US $ 438.49M 8.78M
Peregrine Pharmaceuticals PPHM:US $ 207.8M 91.49M
Rigel Pharmaceuticals RIGL:US $ 196.76M 107.78M
Sangamo Biosciences SGMO:US $ 606.94M 52.72M
Stryker SYK:US $ 8979M 728M
Surmodics SRDX:US $ 93.04M 12.18M
Veracyte VCYT:US $ 362.09M 13.59M
Xencor XNCR:US $ 591.17M 46.5M
Zimmer Biomet Holdings Inc ZBH:US $ 5B 83.2M